3M Company Revenue & Financials

3M's financial performance in fiscal year 2024 reflected the profound transformation underway at the company following the Solventum spinoff and the resolution of its major litigation obligations. Total net revenues from continuing operations were approximately $23.1 billion, reflecting the exclusion of healthcare segment revenues that were transferred to Solventum in April 2024. On an organic basis — stripping out the effects of currency fluctuation and portfolio changes — underlying revenue growth was modestly positive, suggesting that the core industrial and consumer businesses stabilized after several years of declining volumes. Operating margins improved meaningfully in 2024 compared to 2023, reflecting the combined impact of restructuring actions that eliminated approximately 9,500 positions, manufacturing footprint optimization, and reduced litigation-related charges as major settlements were finalized. The company reported adjusted earnings per share in the range of $7.00 to $7.30 for fiscal year 2024, representing a significant improvement from the GAAP losses that characterized 2023 when litigation charge accruals dominated reported results. Free cash flow generation has been one of 3M's most consistent financial attributes, and the company generated approximately $3.6 billion in free cash flow in fiscal year 2024, supporting both the initiation of PFAS settlement payments and continued dividend distributions. 3M's dividend history — 66 consecutive years of annual dividend increases through 2024, making it a member of the elite Dividend Kings group — was meaningfully altered when the company reduced its dividend following the Solventum spinoff, reflecting the smaller revenue base of the post-spinoff entity. This dividend reduction was the first in the company's modern history and represented a significant psychological moment for income-oriented investors who had held 3M as a core dividend growth holding. Debt levels remain elevated relative to pre-litigation periods, with total long-term debt of approximately $12.8 billion as of year-end 2024, reflecting both operational financing needs and the cash requirements associated with legal settlement funding. Management has indicated a commitment to returning the balance sheet to investment-grade metrics consistent with 3M's historical financial conservatism.